These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8900912)

  • 1. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats.
    Kisfalvi K; Friess H; Büchler MW; Tulassay Z; Varga G; Papp M
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):69-74. PubMed ID: 8900912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
    Varga G; Kisfalvi K; D'Amato M; Scarpignato C
    J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
    Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
    Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
    Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
    Otsuki M; Ohki A; Okabayashi Y; Suehiro I; Baba S
    Pancreas; 1987; 2(2):164-9. PubMed ID: 3628222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prolonged administration of long-acting somatostatin on caerulein, CCK-8 and GRP induced pancreatic growth in the rat.
    Hajri A; Aprahamian M; Damgé C
    Regul Pept; 1991 Feb; 32(2):227-37. PubMed ID: 1709749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat pancreas after long-term treatment with the somatostatin analogue octreotide.
    von Schönfeld J; Meisse F; Müller MK
    Exp Physiol; 1995 Nov; 80(6):1031-8. PubMed ID: 8962703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats.
    Göke B; Fenchel K; Knobloch S; Arnold R; Adler G
    Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
    Varga G; Scarpignato C
    Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
    Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH
    Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic effects of camostate on growth and endocrine function of the pancreas in streptozotocin-induced diabetic rats.
    Kogire M; Inoue K; Gu Y; Uchida K; Imamura M
    Proc Soc Exp Biol Med; 1993 Nov; 204(2):201-5. PubMed ID: 8415777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
    Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
    Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
    Lhoste EF; Roebuck BD; Longnecker DS
    Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
    Miyasaka K; Nakamura R; Kitani K
    J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of single and repeated administrations of a protease inhibitor (Camostate) on pancreatic secretion in man.
    Adler G; Müllenhoff A; Bozkurt T; Göke B; Koop I; Arnold R
    Scand J Gastroenterol; 1988 Mar; 23(2):158-62. PubMed ID: 3363288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas.
    Herzig KH; May D; Louie DS; Takahashi T; Göke B; Owyang C
    Digestion; 1990; 46 Suppl 2():195-201. PubMed ID: 1702070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate).
    Göke B; Printz H; Koop I; Rausch U; Richter G; Arnold R; Adler G
    Pancreas; 1986; 1(6):509-15. PubMed ID: 3562444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.
    von Schönfeld J; Rünzi M; Goebell H; Müller MK
    Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.